Could pressure to make money faster kill the next lifesaving pill?
When activist investors target drugmakers, drug-development strategies shift. Patients lose when this happens.
Original Source
Read the full article at Marketwatch →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.